Literature DB >> 16382660

Prevalence of male and female pattern hair loss in Maryborough.

Desmond C C Gan1, Rodney D Sinclair.   

Abstract

Maryborough, in central Victoria has an approximate population of 8000 and census data is well matched for Australia overall. Australia has compulsory voting and registration on the electoral roll. To determine the age-related prevalence of balding among men and women in Maryborough we conducted a postal survey of 5000 men and women aged 20 or older, and 427 were invited to attend for examination. Additional data was collected on dandruff, presence of gray hair. Supplementary questionnaires were sent to 340 children aged 5-9, attending a coeducational primary school. 1456 adults (34.1%) responded to the questionnaire. 396 attended for examination. The prevalence of androgenetic alopecia (AGA) increased with advancing age. 98.6% of men had bitemporal recession and severity was significantly associated with vertex and mid-frontal hair loss (p <0.01) but not age (p = 0.06). In all, 64.4% of women had bitemporal hair loss, and similar to men there was a significant association with mid-frontal hair loss (p =0.042) but not age (p =0.467). One hundred and forty children with completed questionnaires were examined. All 72 females and 68 males were assessed as stage 1 on the mid-line part and with no bitemporal recession (frequency stage 1 = 100%, 95% CI (confidence interval) 97.4%-100%). A significant but weak positive association existed between presence of gray hair and history of dandruff (p<0.01). The prevalence of mid-frontal hair loss increases with age and affects 57% of women and 73.5% of men aged 80 and over.

Entities:  

Mesh:

Year:  2005        PMID: 16382660     DOI: 10.1111/j.1087-0024.2005.10102.x

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN: 1087-0024


  52 in total

Review 1.  [Androgenetic alopecia. Diagnosis and therapy- a current review].

Authors:  U Blume-Peytavi; A Vogt
Journal:  Hautarzt       Date:  2013-11       Impact factor: 0.751

2.  Low-Dose Oral Minoxidil for Female Pattern Hair Loss: A Unicenter Descriptive Study of 148 Women.

Authors:  Rita Rodrigues-Barata; Oscar M Moreno-Arrones; David Saceda-Corralo; Juan Jiménez-Cauhé; Daniel Ortega-Quijano; Diego Fernández-Nieto; Pedro Jaén-Olasolo; Sergio Vaño-Galvan
Journal:  Skin Appendage Disord       Date:  2020-02-21

3.  A Hospital-based Study to Determine Causes of Diffuse Hair Loss in Women.

Authors:  Shashikant Malkud
Journal:  J Clin Diagn Res       Date:  2015-08-01

Review 4.  Androgenetic Alopecia: An Update of Treatment Options.

Authors:  Yanna Kelly; Aline Blanco; Antonella Tosti
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

5.  Patient Satisfaction and Quality of Life Among Adult Women with Androgenetic Alopecia Using 5% Topical Minoxidil.

Authors:  Renata Indelicato Zac; Adilson da Costa
Journal:  J Clin Aesthet Dermatol       Date:  2021-05-01

Review 6.  Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review.

Authors:  Jason M Hirshburg; Petra A Kelsey; Chelsea A Therrien; A Carlo Gavino; Jason S Reichenberg
Journal:  J Clin Aesthet Dermatol       Date:  2016-07-01

Review 7.  Interventions for female pattern hair loss.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Jan Schoones
Journal:  Cochrane Database Syst Rev       Date:  2016-05-26

8.  Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer.

Authors:  Azael Freites-Martinez; Jerry Shapiro; Donald Chan; Monica Fornier; Shanu Modi; Devika Gajria; Stephen Dusza; Shari Goldfarb; Mario E Lacouture
Journal:  JAMA Dermatol       Date:  2018-06-01       Impact factor: 10.282

9.  The Clinical Efficacy and Safety of Autologous Activated Platelet-Rich Plasma Injection in Androgenetic Alopecia.

Authors:  Niluka Dilrukshi Paththinige; Janaka K W Akarawita; Geetha Jeganathan
Journal:  Skin Appendage Disord       Date:  2019-10-04

Review 10.  Female pattern hair loss: current treatment concepts.

Authors:  Quan Q Dinh; Rodney Sinclair
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.